Signaling Pathways
-
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
-
A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective
-
A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
-
A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
A2822 AC480 (BMS-599626)Target: EGFRSummary: HER1/2 inhibitor,selective and efficacious
-
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor
-
A2278 NVP-AEW541Target: Insulin ReceptorSummary: IGF-IR inhibitor, novel, potent and selective
-
A2133 Saracatinib (AZD0530)3 CitationTarget: SrcSummary: Src/Abl inhibitor,potent and selective
-
A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor